Literature DB >> 17936519

Expression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study.

H Zhu1, S Clemens, M Sawchuk, S Hochman.   

Abstract

Dopamine is a catecholaminergic neuromodulatory transmitter that acts through five molecularly-distinct G protein-coupled receptor subtypes (D(1)-D(5)). In the mammalian spinal cord, dopaminergic axon collaterals arise predominantly from the A11 region of the dorsoposterior hypothalamus and project diffusely throughout the spinal neuraxis. Dopaminergic modulatory actions are implicated in sensory, motor and autonomic functions in the spinal cord but the expression properties of the different dopamine receptors in the spinal cord remain incomplete. Here we determined the presence and the regional distribution of all dopamine receptor subtypes in mouse spinal cord cells by means of quantitative real time polymerase chain reaction (PCR) and digoxigenin-label in situ hybridization. Real-time PCR demonstrated that all dopamine receptors are expressed in the spinal cord with strongly dominant D(2) receptor expression, including in motoneurons and in the sensory encoding superficial dorsal horn (SDH). Laser capture microdissection (LCM) corroborated the predominance of D(2) receptor expression in SDH and motoneurons. In situ hybridization of lumbar cord revealed that expression for all dopamine receptors was largely in the gray matter, including motoneurons, and distributed diffusely in labeled cell subpopulations in most or all laminae. The highest incidence of cellular labeling was observed for D(2) and D(5) receptors, while the incidence of D(1) and D(3) receptor expression was least. We conclude that the expression and extensive postsynaptic distribution of all known dopamine receptors in spinal cord correspond well with the broad descending dopaminergic projection territory supporting a widespread dopaminergic control over spinal neuronal systems. The dominant expression of D(2) receptors suggests a leading role for these receptors in dopaminergic actions on postsynaptic spinal neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936519      PMCID: PMC2185067          DOI: 10.1016/j.neuroscience.2007.07.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  61 in total

1.  D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function.

Authors:  B Levant; K E McCarson
Journal:  Neurosci Lett       Date:  2001-04-27       Impact factor: 3.046

2.  Neurogenesis and neuronal migration in the neonatal rat forebrain anterior subventricular zone do not require GFAP-positive astrocytes.

Authors:  A K Law; V Pencea; C R Buck; M B Luskin
Journal:  Dev Biol       Date:  1999-12-15       Impact factor: 3.582

3.  D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain.

Authors:  Y L Hurd; M Suzuki; G C Sedvall
Journal:  J Chem Neuroanat       Date:  2001-07       Impact factor: 3.052

4.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

5.  A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride.

Authors:  M L Bouthenet; M P Martres; N Sales; J C Schwartz
Journal:  Neuroscience       Date:  1987-01       Impact factor: 3.590

6.  Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones.

Authors:  S M Fleetwood-Walker; P J Hope; R Mitchell
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

7.  Neurotrophin expression by spinal motoneurons in adult and developing rats.

Authors:  C R Buck; K L Seburn; T C Cope
Journal:  J Comp Neurol       Date:  2000-01-17       Impact factor: 3.215

8.  The characterization of [3H]sulpiride binding sites in rat striatal membranes.

Authors:  J Imafuku
Journal:  Brain Res       Date:  1987-02-03       Impact factor: 3.252

9.  Studies on dopamine-, tyrosine hydroxylase- and aromatic L-amino acid decarboxylase-containing cells in the rat diencephalon: comparison between formaldehyde-induced histofluorescence and immunofluorescence.

Authors:  G Skagerberg; B Meister; T Hökfelt; O Lindvall; M Goldstein; T Joh; A C Cuello
Journal:  Neuroscience       Date:  1988-02       Impact factor: 3.590

10.  Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.

Authors:  A Dubois; M Savasta; O Curet; B Scatton
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

View more
  35 in total

1.  Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats.

Authors:  K Kawamoto; K Otsuguro; M Ishizuka; S Ito
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Neonatal androgen-dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons.

Authors:  Samuel S Pappas; Chelsea T Tiernan; Bahareh Behrouz; Cynthia L Jordan; S Marc Breedlove; John L Goudreau; Keith J Lookingland
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

3.  Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.

Authors:  Ji-Young V Kim; Dipti V Tillu; Tammie L Quinn; Galo L Mejia; Adia Shy; Marina N K Asiedu; Elaine Murad; Alan P Schumann; Stacie K Totsch; Robert E Sorge; Patrick W Mantyh; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

4.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

5.  A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice.

Authors:  Salim Megat; Stephanie Shiers; Jamie K Moy; Paulino Barragan-Iglesias; Grishma Pradhan; Rebecca P Seal; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2017-11-22       Impact factor: 6.167

6.  The activation of D2 and D3 receptor subtypes inhibits pathways mediating primary afferent depolarization (PAD) in the mouse spinal cord.

Authors:  Jonathan J Milla-Cruz; Elvia Mena-Avila; Jorge R Calvo; Shawn Hochman; Carlos M Villalón; Jorge N Quevedo
Journal:  Neurosci Lett       Date:  2020-07-16       Impact factor: 3.046

7.  Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine.

Authors:  Samuel S Pappas; Tom Kennedy; John L Goudreau; Keith J Lookingland
Journal:  Neuropharmacology       Date:  2011-05-13       Impact factor: 5.250

8.  Presynaptic Inhibition of Primary Nociceptive Signals to Dorsal Horn Lamina I Neurons by Dopamine.

Authors:  Yong Lu; Maksym Doroshenko; Justas Lauzadis; Martha P Kanjiya; Mario J Rebecchi; Martin Kaczocha; Michelino Puopolo
Journal:  J Neurosci       Date:  2018-08-24       Impact factor: 6.167

9.  Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Authors:  Quentin Barraud; Ibrahim Obeid; Incarnation Aubert; Gregory Barrière; Hugues Contamin; Steve McGuire; Paula Ravenscroft; Gregory Porras; François Tison; Erwan Bezard; Imad Ghorayeb
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

10.  Unaltered D1, D2, D4, and D5 dopamine receptor mRNA expression and distribution in the spinal cord of the D3 receptor knockout mouse.

Authors:  Hong Zhu; Stefan Clemens; Michael Sawchuk; Shawn Hochman
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2008-09-17       Impact factor: 1.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.